Membrane chromatography for AAV full capsid enrichment: Process development to scale up.
J Chromatogr B Analyt Technol Biomed Life Sci
; 1244: 124258, 2024 Aug 15.
Article
em En
| MEDLINE
| ID: mdl-39089064
ABSTRACT
The recent FDA approval of several adeno-associated virus (AAV)-based gene therapies is driving demand for AAV production. One of the biggest AAV manufacturing challenges is removing "empty" capsids, which do not contain the gene of interest. Anion exchange chromatography has emerged as the leading solution for scalable full capsid enrichment. Here we develop a process for the baseline separation of empty and full AAV capsids using anion exchange membrane chromatography. This process development approach utilized AAV serotypes 8 and 9 and traverses initial screening of separation conditions up to manufacturing-scale processes. Process development of a two-step elution was performed via response surface DoE, exploring conductivity and the length of the first elution step. The results from response surfaces were used to construct statistical models of the process operating space. These models provide optimal conditions for recovery and purity, both of which can exceed 70 %. Model predictions were then validated at small scale prior to scale-up. We present the results from our scale-up purification and show that purity and yield are consistent with the results obtained from the response surface model.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Dependovirus
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article